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Abstract 
Developments in biotechnologywould provide many new opportunities for livestock agriculture, human 
medicine, and animal conservation. Nuclear cloning involves the production of animals that are genetically 
identical to the donor cells used in a technique known as nuclear transfer. However, at present it is an inefficient 
process in farm animal and small number of the embryos transferred to the reproductive tracts of recipient 
mother result in healthy, long-term surviving clones. Recent cloning research also reveals high failure rates, 
premature deaths, and dysfunctioning of internal organs.Food products from healthy clones, i.e. meat or milk, 
did not differ from products from healthy conventionally bred animals.  Even though the food products of cloned 
animals showed no differences with conventional offspring or products,throughout the world there is significant 
public opposition to the introduction of meat and milk from cloned animals and their progeny into the food 
supply. Cloning also threatens the welfare of surrogate mothers, the underlying health of the animals and the 
next generation, the consequential effect on food safety are critical aspects that require investigation to gain 
regulatory and consumer acceptance.Data on clones of farmed species for food production other than cattle and 
pigs have remained limited and do not allow for assessment of food safety or animal health and welfare aspects. 
Keywords: Biotechnology, Cloning, Food safety, Nuclear transfer, Trans generational effects, 
 
1. Introduction 
Assisted reproductive techniques such as artificial insemination, embryos transfer, in vitro fertilization, embryo 
micromanipulation and cloning have been developed to obtain offspring from genetically individuals or infertile 
animals (Andrabi and Maxwell, 2007).Cloning refers to producing genetically identical individual to donor cells 
and copying gene which involves the creation of individual that drives its genes from a single other individual; it 
is also referred to as asexual reproduction. Cloning is a powerful technique and potentially it could be used for 
multiplication of elite animals, conservation as well as propagation of endangered species, to minimize the 
genetic variation in experimental animal and for the production of stem cells for therapeutic purposes, as 
therapeutic cloning (Das et al., 2003).  
Cloning holds the promise of by passing conventional breeding procedures to allow creation of thousands of 
precise duplicates of genetically engineered animals. In remote areas, where sampling and storage of adequate 
samples of semen and embryos is not practical, one could use clone samples from diverse animals for 
conservation of the available genetic diversity. The local breeds may contain valuable genes that confer 
adaptation, especially to heat tolerance or disease resistance, and there is an urgent need to prevent their 
extinction which can achieve by cloning techniques (Duszewska and Reklewski, 2007). 
Most recently, there is growing scientific and public interest in using nuclear transfer techniques to facilitate 
production improvement and the rescue of endangered species, or even to restore them after the extinction of 
intact organisms (Rudenko et al., 2004).Despiteall the efforts in cloning, there arelow efficiency of cloning and 
high incidence of developmental abnormalities of cloned animals. Therefore the purpose of this review is to 
compile available literatures on challenges and difficultiesattributable to the inefficiency of application 
associated with producingcloned animals from nuclear transfer. 
 
2. Challenges of Cloning  
There are many technical challenges related to current technologies used in animal cloning,the adverse effects 
observed are related to systemic disturbances in the regulation of the genome and cannot be confined to single 
genetic information. Various effects are summarized under the expression 'Large Offspring Syndrome' (LOS), 
but these effects have many differing causes and a broad range of symptoms. These technical problems and 
observed adverse effects give rise to questions concerning food safety, animal welfare and the biological 
integrity of cloned animals (EGE,2008). 
 
2.1. Animal welfare 
Cloning research reveals abnormalities and high failure rates, problems widely acknowledged by scientists in the 
field and potentially indicative of poor animal welfare (Han etal., 2003).The health and welfare of a significant 
proportion of clones, mainly within the young period for bovines and perinatal period for pigs, have been found 
to be adversely affected, often severely and with a fatal outcome (EFSA, 2008). The list of problems from which 
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clones have suffered is extensive, including diabetes, enlarged tongues, malformed faces, intestinal blockages, 
shortened tendons, deformed feet, weakened immune systems, respiratory distress, circulatory problems, and 
dysfunctional hearts, brains, livers, and kidneys (Panarace et al.,2007). 
Cloning also threatens the welfare of surrogate mothers, most exhibited placental abnormalities that pose 
serious health risks not only to the developing fetus and offspring, but also to the surrogate mothers carrying the 
pregnancies, and have resulted in the deaths of both the fetuses and the surrogate mothers (Humpherys et al., 
2002). 
As the animal welfare group Compassion in World Farming points out at EGE there are several issues 
where cloning procedures are concerned, Invasive medical interventions at the level of donor animals, invasive 
medical interventions as for oocyte extraction in some animal species, suffering caused to surrogate mothers, 
abnormal foetal development and late pregnancy mortality (D'Silva, 2007). 
 
2.2. Public and social acceptance 
Many peoples were concerned that cloning could result in food that was unsafe for human consumption. This 
was partly a function of the perceived high incidence of miscarriages and deformed and short-lived offspring 
resulting from the process. It was also because of a fear that the process of cloning might somehow create new 
diseases or affect the food in a way that would be harmful to humans. Moreover, the negative impact on human 
health and wellbeing may only become apparent at some point in the future (EFSA, 2009). 
Public opinion against cloning is apparent throughout the world. According to survey conducted in 2008, 
61% of European citizens believe the cloning of animals to be “morally wrong (The Gallup Organization, 2008). 
In addition one survey in America showed that 64% of Americans think cloning is “morally wrong,” and another 
63% would not buy cloned food even it were labeled as “safe” (Tucker-Foreman, 2012). 
Cloning has given rise to a massive ethical debate, including reports by bioethics committees and many 
books and articles. There are few enthusiastic advocates of cloning, but a number of bioethicists have tried to 
show that popular responses and even the more sophisticated philosophical arguments against cloning are naive, 
and cannot be sustained. In a similar, defensive way, liberals have argued that while cloning may not be very 
desirable, we should not stop other people from doing it, because that would interfere with freedom (Jaenisch, 
2003). 
 
2.3. Food safety 
The composition of food products derived from clones have found that they have the same composition as milk 
or meat from conventionally-produced animals. Milk and meat from clones produced by embryo splitting and 
nuclear transfer of embryonic cells have been entering the human food supply for over 20 years with no evidence 
of problems (Takahashi and Ito, 2004). As there is no fundamental reason to suspect that clones will produce 
novel toxins or allergens, the main underlying food safety concern was whether the nuclear transfer cloning 
process results in subtle changes in the composition of animal food products (Rudenko et al., 2004). 
In 2008 European Food Safety stated that there was no clear evidence to suggest the difference between 
food products from cloned and conventionally bred animals  on the ground of food safety, but public debate lead 
review of scientific investigationand again in2011they concluded that there was no scientific evidence to suggest 
that cloned meat or milk could not be eatensafely, but restricted that  alicense for the sale products was necessary 
and currently, there is no existing test for the detection of the characteristics cloned or its offspring (EFSA, 2008). 
 
3. Difficulties of Cloning 
3.1. Parturition difficulties (Dystocia) 
Because cloned fetuses are often abnormally large, labor and delivery are likely to be painful and stressful, and 
the mother is less likely to survive the pregnancy. In one published study describing a cattle cloning project, 3 of 
12 surrogate mothers died during pregnancy. Intervention is often believed necessary to deliver cloned offspring, 
as gestation length in nuclear transfer pregnancies is typically prolonged and the birth weight of cloned calves 
may be 25% heavier than normal(Turner, 2002).  
Newborn cloned calves display functional adrenal glands, so this extended gestation may be due to failure 
of the placentae to respond to fetal cortisol near term or to a lack of adrenocorticotropic hormone release from 
the fetus and oversized cloned offspring add to the birth complications (Chavatte-Palmer et al., 2002).At 
agriculture research, the occurrence of prolonged gestation and the risk of dystocia initially prompted the 
delivery of clones by elective caesarean-section, following a brief exposure to exogenous corticosteroids (Rhind 
et al., 2004). 
 
3.2. Placental abnormalities 
A failure of the placenta to develop and function correctly is a common feature amongst clones and the majority 
of early pregnancy failures, before placentome formation, are attributed to an inadequate transition from yolk sac 
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to allantoic-derived nutrition, with poor allantoic vascularization in sheep (De-Sousa et al., 2001).  
Furthermore, there is reported evidence of immunological rejection contributing to early embryonic loss 
(Hill et al., 2002). Typically in cattle, 50% to 70% of pregnancies at day 50 are lost throughout the remainder of 
gestation and up to term. This is in stark contrast to only 0% to 
5% loss with artificial insemination or natural mating over the same period (Lee et al., 2004). In extreme 
cases, placentomes are entirely absent at day 50, shortly thereafter, these pregnancies fail. More commonly, 
cloned placentae only have half the normal number of placentomes, display compensatory overgrowth and are 
edematous. Of particular concern are the losses in the second half of gestation; especially the occurrence of 
hydroallantois, i.e. the excess accumulation of fluid within the allantois (Former, 2005). Abnormal pregnancy 
development could be determined by measuring specific components present in maternal serum with early 
detection allowing early elective abortion (Chesne et al., 2002). 
 
3.3. Post-natal viability (death) 
A study showed that around 80% of cloned calves delivered at term are alive after 24 h. Two-thirds of the 
mortality within this period is due to a spinal fracture syndrome through the cranial epiphyseal plate of the first 
lumbar vertebrae or to deaths that occurred either in uterus or from dystocia (Wells et al., 2004). Surviving 
newborn clones have altered neonatal metabolism and physiology, possibly due to placental abnormalities, and it 
takes time for these processes to adjust to normal. Typically an additional 15% of calves initially born alive die 
before weaning (Chavatte-Palmer et al., 2002). The most common mortality factors during this period are 
gastroenteritis and umbilical infections. Other abnormalities noted include defects in the cardiovascular, 
musculoskeletal and neurological systems, as well as susceptibility to lung infections and digestive disorders Lee 
et al., 2004). The proportion of cloned calves that survive to weaning is significantly greater for those derived 
from quiescent G0 donor cells (81%) than for those derived from G1 cells (50%) (Wells et al., 2003).  
 
3.4. Trans-generational effects 
Experiments on ratshow that epigenetic effects can be found over three following generations, transgenerational 
epigenetic inheritance in response to various conditions has been documented in many eukaryotes and may play 
an important role in mammals. In particular, environmental influences such as stress extreme temperature and 
infectious disease may induce a number of epigenetic modifications leading to the silencing or activation of 
specific genes, especially when pregnant females are maintained in conditions resulting in stress in the dam and 
foetus. The epigenetic modifications observed in the offspring of those pregnancies may then be transmitted to 
their progeny. These phenomena, which are considered as mechanisms of adaptation, have been found to be 
reversible after three generations in rats (EFSA, 2009). 
In the mating of cloned females with cloned males, with these mating in sheep, cattle and mice there is no 
evidence of the placental abnormalities and only large birth weights is recorded in the clone generation. It has 
also been claimed that the obese phenotype observed in cumulus cell mouse clones is not heritable following 
mating with cloned males derived from fibroblasts of the same mouse strain (Ogura et al., 2002). The most 
convincing evidence for the lack of transmission of any obvious deleterious recessive genetic or epigenetic trait 
has been provided following the mating of cloned male and cloned female mice obtained from the same cell line. 
The resulting offspring were phenotypically normal, lacking the fetal and placental overgrowth and open-
eyelids-at-birth characteristic of their cloned parents (Oback et al., 2003). 
Clone-associated phenotypes are not transmitted to offspring following sexual reproduction, implies that 
they are epigenetic in nature and that any errors in the surviving clones appear to be reset or corrected during 
gametogenesis. It is critical to investigate this phenomenon more thoroughly, as evidence exists for the germ line 
transmission of epigenetic states at various endogenous loci and in more artificial situations, following nuclear-
cytoplasmic incompatibility (Ogonuki et al., 2002). 
 
Conclusion and Recommendations 
Genetic engineering of animals has made its mark on the global stage of biotechnology. Particularly Cloning has 
the potential to improve the efficiency of trans-genesis in these applications, as well as a role for the 
multiplication of animals of proven production.Somatic Cell Nuclear Transfer can produce healthy clones, but a 
portion of the animal clones suffered from developmental abnormalities likely due to epigenetic dysregulation 
and died at various stages of development. For some of the live animal clones, in particular calves and piglets, 
health and welfare were compromised specifically within the perinatal and juvenile period. Also some of the 
surrogate dams were affected due to abnormal pregnancies. High failure rates, defects, disabilities, and the 
premature deaths of both surrogate mothers and offspring have weighed down the application of biotechnology 
to farm animals. The decisions we make now about genetic engineering and cloning will have profound effects 
on the future of our relationship to farm animals and to farming. Despite the present limitations of cloning, the 
milk and meat from these livestock animals does not appear to be materially different from those of 
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.62, 2018 
 
38 
conventionally bred animals. Based on the above review and conclusion, the following recommendations are 
forwarded: 
 If the application and acceptability of this emerging technology are to be improved, it is 
important to understand the biology behind nuclear cloning so as to improve the health and 
viability of the cloned animals produced and of their surrogate mothers. 
 Even though vast research efforts are being focused on trying to better understand the source of 
the problems, experts and veterinary professional need to better understand the medical 
problems associated with cloned animals in order to develop more effective treatments to reduce 
pregnancy loss and neonatal morbidity and mortality levels. 
 It is desirable that the health and wellbeing of cloned animals should be equal to non-clones and 
that any deficit should be minimized and thoroughly justified in terms of the benefits expected 
from the application. Achieving this goal will only result from improvements in the efficiency of 
the cloning process. This is the prime concern of many international organizations recently 
workingin this field. 
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